IREN to Release Q1 FY25 Results on November 26, 2024
SYDNEY, Nov. 13, 2024 (GLOBE NEWSWIRE) — Iris Energy Limited (NASDAQ: IREN) (together with its subsidiaries, “IREN”) today announced that […]
Oculis to Present at the Stifel 2024 Healthcare Conference
ZUG, Switzerland, Nov. 13, 2024 (GLOBE NEWSWIRE) — Oculis Holding AG (Nasdaq: OCS) (“Oculis”), a global biopharmaceutical company purposefully driven […]
Telix and Eckert & Ziegler to Partner on Actinium-225 Production Technology
MELBOURNE, Australia and BERLIN, Nov. 13, 2024 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces […]
Himax Technologies, Inc. to Attend UBS Global Technology and AI Conference on December 2 – 5, 2024
TAINAN, Taiwan, Nov. 13, 2024 (GLOBE NEWSWIRE) — Himax Technologies, Inc. (“Himax” or “Company”) (Nasdaq: HIMX), a leading supplier and […]
First Half of Fiscal Year 2024 Unaudited Financial Results
SINGAPORE, Nov. 13, 2024 (GLOBE NEWSWIRE) — Davis Commodities Limited (Nasdaq: DTCK) (the “Company” or “Davis Commodities”), an agricultural commodity […]
TSX News -
Valeura Energy Inc.: Third Quarter 2024 Results
SINGAPORE, Nov. 13, 2024 (GLOBE NEWSWIRE) — Valeura Energy Inc. (TSX:VLE, OTCQX:VLERF) (“Valeura” or the “Company”) reports its unaudited financial […]
VEON appoints UHY LLP as auditors for VEON Group’s 2024 PCAOB Audit
Amsterdam and Dubai, 13 November 2024 – VEON Ltd. (Nasdaq: VEON, Euronext Amsterdam: VEON), a global digital operator, (“VEON” or, […]
Kingsoft Cloud to Report Third Quarter 2024 Financial Results on November 19, 2024
BEIJING, Nov. 13, 2024 (GLOBE NEWSWIRE) — Kingsoft Cloud Holdings Limited (NASDAQ: KC and HKEX: 3896) (“Kingsoft Cloud” or the […]
Mustang Energy Corp. Enters Option Agreement to Acquire Skyharbour’s 914W Uranium Project and Welcomes Jordan Trimble as Strategic Advisor
VANCOUVER, British Columbia, Nov. 13, 2024 (GLOBE NEWSWIRE) — Mustang Energy Corp. (CSE:MEC, OTC:MECPF, FRA:92T) (“Mustang” or the “Company”) is excited […]
89bio, Inc. Announces Upsized Pricing of $125.0 Million Public Offering of Common Stock and Pre-Funded Warrants
SAN FRANCISCO, Nov. 12, 2024 (GLOBE NEWSWIRE) — 89bio, Inc. (“89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the […]
